Neoplasm
130
10
10
85
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
26 trials with published results (20%)
Research Maturity
85 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
13.8%
18 terminated out of 130 trials
82.5%
-4.0% vs benchmark
6%
8 trials in Phase 3/4
31%
26 of 85 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 85 completed trials
Clinical Trials (130)
Phase I Study of Intratumoral Macrophage Exosomes With Mechanobiological Reprogramming in Advanced Solid Tumors
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
Role of the Pharmacist in Detection of Drug Interactions Before Antitumor Treatment Initiation
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Sarcopenia and CRP-TyG Index (CTI) as Predictors of Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer
Cardiotoxicity Assessment and Reduction Through Exercise in BREAST Cancer
Preoperative Radiation Therapy and Immediate Breast Reconstruction
Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors
Using Artificial Intelligence to Guide Fluid Therapy During Major Cancer Surgery: A Randomized Controlled Trial
CARE Study: Cancer, Asian Americans, and Relationship Enrichment
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors
Evaluation of the Impact of the Clinical Pharmacist in Oral Therapies in Oncology.
Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors
The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial
A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers